Analyst firms · Needham · MDT
Needham MDT price target and rating history
Medtronic plc. (MDT) · Health Care
Needham rates Medtronic plc. (MDT) Buy with a $114 price target, as of its latest action on Aug 27, 2026. It has published 7 rating actions on MDT since November 2021, including 1 upgrade and 1 downgrade. Across 7 firms with a MDT price target in the last 12 months, the median target is $100. Needham's $114 is 14% above that.
- Current rating
- Buy
- Price target
- $114
- Median target, all firms
- $100
- Actions on MDT
- 7
Needham price target on MDT
Every Needham rating on MDT
- Aug 27, 2026
- Feb 9, 2026
- May 27, 2022DowngradeNeedham downgrades to Hold from Buy
- Feb 23, 2022
- Jan 25, 2022
- Dec 16, 2021
- Nov 23, 2021
How other firms rate MDT
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Barclays | Equal Weight | $95 | Oct 7, 2026 |
| Needham | Buy | $114 | Aug 27, 2026 |
| UBS | Buy | $100 | Jul 28, 2026 |
| BTIG | Buy | $90 | Jun 4, 2026 |
| Goldman Sachs | Neutral | $84 | May 21, 2026 |
| Citigroup | Buy | $117 | Feb 3, 2026 |
| Wells Fargo | Overweight | $114 | Jan 30, 2026 |
| William Blair | Outperform | Jan 6, 2026 |
Questions about Needham and MDT
- What is Needham's price target for MDT?
- Needham's latest stated price target for Medtronic plc. (MDT) is $114, from its action on Aug 27, 2026.
- What is Needham's rating on MDT?
- Needham rates MDT Buy, a bullish rating, as of Aug 27, 2026.
- When did Needham last change its view on MDT?
- On Aug 27, 2026, Needham raises its price target to $114 from $101, keeps Buy.
- How does Needham's MDT target compare with other analysts?
- Across 7 firms with a MDT price target in the last 12 months, the median target is $100. Needham's $114 is 14% above that.
More MDT rating histories
- Barclays3
- UBS4
- BTIG3
- Goldman Sachs4
- Citigroup6
- Wells Fargo6
- RBC Capital Markets3
- Oppenheimer4
- Morgan Stanley4
- Raymond James3
- Truist Securities3
- Credit Suisse3
All Needham ratingsMDT news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.